InvestorsHub Logo
Followers 20
Posts 1674
Boards Moderated 0
Alias Born 09/25/2019

Re: biowreck post# 260888

Friday, 04/03/2020 3:18:45 AM

Friday, April 03, 2020 3:18:45 AM

Post# of 426487
bio-direct from Du opinion p. 13: " All of the Asserted Patents were initially rejected as obvious, but the patent examiner responsible for reviewing them later issued materially identical statements of allowance permitting the Asserted Patents to issue because he found that certain secondary considerations of non obviousness made the Asserted Claims patentable. (Id.at 61-65.) He specifically found the pending claims patentable because “Applicant was able to overcome the above 103 obviousness rejection
by showing: 1 - Unexpected results, and 2 -Long felt unmet medical need.” (See, e.g.Ex.38 at 1831.)

I also could not believe this.

I recommend you read the opinion, it will give you a much better perspective.

https://www.scribd.com/document/454018521/Amarin-Pharma-
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News